Interaction between type I IFN and B cell parameters in SLE patients were previously observed in response to Jak blockade (baricitinib), where decrease of anti-dsDNA antibodies was associated with reduced IFN gene signatures43. Here, IFNA1 is linked to systemic lupus erythematosus.